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The study of endophenotypes may be a viable strategy to tackle the genetic complexity and phenotypic heterogeneity of psychosis, 
but this research direction is relatively under-developed in China as compared to Western countries. We have recently initiated 
one of the first family studies of endophenotypes for psychosis in China. Patients entering an established early psychosis 
intervention service are recruited into this research project for phenotyping, endophenotyping and genotyping. At the 
endophenotypic level, four domains (neurological soft signs, neurocognition of prospective memory, social cognition of facial 
emotion recognition, and affective cognition of anticipatory and consummatory pleasure) are studied in the sample of patients 
with psychosis and their unaffected siblings. This article illustrates the benefit of a research-oriented clinical programme and its 
findings based on the data collected as of early 2011. 
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1  Development of a family study for neurocogni-    
tive endophenotypes and incorporating the research 
project into an established clinical programme 
The phenotypic heterogeneity of schizophrenia is believed 
to contribute to the difficulties in identifying susceptibility 
genes of large effect size (Odds Ratio > 1.5) [1,2]. A high 
level of heterogeneity is understandable in light of the 
uncertain biological validity of the current operational 
diagnostic system as well as recent evidence from psychiatric 
epidemiological studies which suggests that psychosis is a 
continuous phenotype [3]. Gottesman et al. [4–6] proposed 
that endophenotypes, conceptualised as markers which bridge 
the gap between genes and symptoms (phenotype), may 
clarify the elusive disease processes of psychiatric disorders, 
and offer a potential solution to overcome phenotype hetero-  
geneity in genetic studies. This endophenotype approach [6] 
and the recent concept of continuous phenotype [3] would 
require the recruitment of clinically or genetically high risk 
groups for studies, because these unaffected individuals 
may be “carriers” of vulnerable genes. Many potential 
endophenotypic markers are neurocognitive dysfunctions, 
such as working memory and attention [7,8]. It is possible 
that neurocognitive dysfunctions which are more closely 
related to the underlying neurobiological basis of psychosis 
may better predict the development of psychotic illness 
among high-risk individuals and the long-term clinical 
outcome of patients with established psychosis, than psychotic 
symptoms and other routine clinical parameters. It would be 
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of much practical interest to clinicians if biological markers 
with predictive validity can be found. 
Recent studies suggest that schizophrenia and bipolar 
disorder have closely related genetic basis [9], and therefore 
can be studied using the same endophenotype paradigm. To 
date, a limited number of research projects in Western 
countries have been specifically developed to address issues 
concerning endophenotypes, e.g. the Consortium of Genetics 
of Schizophrenia [1,7,8], but similar projects are rare in 
China. Given differences in ethnicity, environment, language, 
and culture between Asian and Western countries, China 
has developed its own framework for endophenotype research, 
viz. the Consortium of Human Information and Neurocognitive 
Endophenotype (CHINE) [10]. 
We are currently developing a research project to 
specifically examine a number of candidate endophenotypes 
for psychosis in the Hong Kong Chinese population. In 
Hong Kong, a well-established early intervention programme 
for psychosis provides a good foundation for such a 
research project. The Early Assessment Service for Young 
People with Psychosis (EASY) in Hong Kong is a clinical 
programme established in 2001 [11], which aims to provide 
early detection and intervention for young people aged 
between 15 and 25 developing first-onset psychotic disorders. 
Patients receive care under a case management approach 
from the early intervention team for up to three years after 
the onset of psychosis, and their clinical outcome and 
course of illness are monitored by the same team of staff. 
Since its work involves a high degree of engagement of 
patients and their families, continuity of care, and access to 
a large cohort of first-onset psychosis patients who are 
medication-naive and free from the confounding effect of 
long term hospitalisation, the early intervention programme 
provides an excellent opportunity to study endophenotype 
for psychosis.  
Making use of this valuable cohort of first-onset patients, 
a group of clinicians and scientists from Hong Kong and 
Beijing launched a joint research-based clinical programme 
in Castle Peak Hospital of Hong Kong to investigate a 
number of potential endophenotypic markers using a family 
study approach. In addition to clinical assessment (pheno-
typing), detailed endophenotype measures and DNA collection 
of both recruited patients and their first-degree relatives are 
part of the study paradigm. A number of neurocognitive 
function assessments thought to have high translational 
potential have been chosen as potential endophenotypes in 
this study while the inclusion of proteomics in this project 
may provide further opportunity to investigate the effect of 
genotype on psychosis. 
The main objective of this research-based clinical 
programme is to examine specifically the prevalence of 
several neurocognitive dysfunctions in schizophrenia and 
bipolar disorder, which include neurological soft signs, 
neurocognitive parameters such as prospective memory that 
relate closely to clinical problems (e.g. forgetting to take 
medications), affective cognition such as anticipatory and 
consummatory pleasure, and social cognition such as facial 
emotional recognition. We also aim to test the endophenotypic 
properties of these neurocognitive dysfunctions based on 
the criteria proposed by Gottesman and Gould [6], i.e. (1) 
illness association; (2) state independence; (3) familial as-
sociation; (4) co-segregation; (5) heritability. In addition, 
we also examine the relationship between longitudinal out-
come (up to four years after onset of psychosis) and these 
neurocognitive endophenotypes. This research project is 
expected to continue for four years with a recruitment target 
of 100 families of patients with first-onset psychosis. 
This study would recruit young patients aged 15–25 with 
first-onset psychotic disorders as they present to the early 
intervention service. As normally these patients are to be 
followed-up clinically at an interval of around 1–8 weeks 
for up to three years, the programme presents researchers 
with a valuable opportunity to conduct endophenotyping in 
a longitudinal manner at the sixth month, the first year, and 
the second year. This study would also recruit unaffected 
siblings for endophenotyping and parents for genotyping. 
The clinical follow-up in the outpatient clinic is an effective 
“contact point” for the researchers involved to recruit family 
members. In addition, the sample group recruited from the 
early intervention service is medication-naïve at service 
entry and is not subject to the confounding effects of long- 
term hospitalisation, long-term unemployment and social 
isolation (which may be present secondary to longstanding 
psychosis) on neurocognitive dysfunctions. Our subjects 
include not only patients with schizophrenia but also those 
with bipolar disorder.  
2  Preliminary findings  
As of early 2011, we have recruited 71 patients with 
schizophrenia, 39 patients with bipolar disorder, and 60 
unaffected first-degree relatives of patients with psychosis. 
Using the cross-sectional data we obtained, the relationship 
between clinical status (i.e. schizophrenia and bipolar disorder) 
and prospective memory and neurological soft signs was 
examined. These two neurocognitive functions were also 
examined in genetically high-risk group and in control 
subjects. As longitudinal data has yet to be collected and the 
current sample size remains relatively small, we focus, in 
this article, only on illness association and familial association, 
and not state independence and heritability. Data on affective 
cognition and social cognition are not discussed in this 
article due to the same reasons. 
2.1  Neurological soft-signs in patients with schizophrenia 
and their unaffected siblings, and patients with bipolar 
disorder 
Empirical evidence supporting neurological soft signs (NSS) 
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as a potential endophenotypic marker of psychosis has 
accumulated in the literature. A recent review paper summ-      
arised the previous findings and concluded that neurological 
soft signs are associated with schizophrenia at different 
stages of illness (prodromal, drug-naive, first-onset, and 
chronic remitted schizophrenia), and are also found in unaff-   
ected relatives of patients with schizophrenia [12]. In this 
study, we examined motor coordination, sensory integration, 
and inhibition, using the Cambridge Neurological Inventory 
(CNI) in our sample. The presence and severity of neurological 
soft signs (as indicated by the raw scores of each subset of 
CNI) in patients with schizophrenia and their unaffected 
relatives, and patients with bipolar disorder are presented in 
Figure 1. We found that the levels of neurological soft signs 
in patients with schizophrenia and bipolar disorder are sim-
ilar to each other, and are higher than in unaffected siblings 
and healthy subjects. This is consistent with our expectation 
that the two phenotypes (schizophrenia and bipolar disorder) 
share a common potential endophenotypic marker of neu-
rological soft signs. The level of neurological soft signs in 
unaffected relatives of patients with schizophrenia was 
moderate, while that in healthy subjects was the lowest. Our 
findings support the illness association property of neuro-
logical soft signs (total score) in patients with schizophrenia 
[F(2, 68) = 13.1; P < 0.01] and bipolar affective disorder 
[F(2, 54) = 14.0; P < 0.01]. Moreover, NSS also seemed to 
have familial association property in schizophrenia because 
unaffected relatives of patients with schizophrenia per-
formed more poorly than healthy subjects [F(2, 85) = 13.1;  
P < 0.01].  
2.2  Prospective memory in first-onset schizophrenia 
and their nonpsychotic siblings 
Prospective memory (PM) is the ability to remember to 
carry out intended action(s) in the future, and can be 
classified into event-based, time-based and activity-based 
PM. This ability is related to everyday functioning such as 
remembering to take medications and to attend a medical  
 
Figure 1  Neurological soft signs among patients with schizophrenia (n = 
41), their unaffected relatives (n = 58), patients with bipolar disorder (n = 
27), and healthy subjects (n = 29). NSS_total, total score of soft signs; 
NSS_moto, motor coordination subscale score; NSS_sens, sensory integra-
tion subscale score; NSS_inhi, inhibition subscale score. 
appointment, and is therefore of high translational potential. 
Our research group used a dual-task behavioural paradigm 
[13] to assess these functions. Previous studies have found a 
high test-retest reliability of this PM instrument [14]. 
Empirical evidence has shown that PM has a distinct neural 
correlate in Brodmann’s Area 10 (frontal pole) [15,16]. 
Moreover, a few studies have suggested that PM deficit is 
present in clinically and genetically high risk groups, e.g. in 
patients with schizotypal personality disorder [13,17]. In the 
light of these previous findings, we hypothesised that PM is 
an endophenotype of schizophrenia. The methodology of 
this study has been discussed elsewhere [18]. Our findings 
suggest that schizophrenia has significant group effect on 
PM performance even after other memory, attention, and 
executive functions were controlled for. Our findings 
therefore strongly support the illness association property of 
PM in first-onset schizophrenia (mean duration of illness: 
1.7 years). Given that Wang et al. [19] found in a meta- 
analysis that patients with chronic schizophrenia (average 
duration of illness ranged from 4.7 to 26.1 years) had 
impaired PM function, our findings provided preliminary 
evidence that PM may have state-independence property 
regardless of illness duration.  
Figure 2 shows the mean PM scores of the three groups. 
Although we found no significant difference in PM perform-    
ance between siblings and healthy subjects, the mean PM 
score of the sibling group is intermediate between those of 
the schizophrenia group (which had the lowest PM scores) 
and healthy subjects (which had the highest PM scores), and 
a trend suggesting familial association of PM could be ob-
served in the findings. 
3  Discussion 
To date we are only able to report preliminary findings 
based on a relatively small initial sample, and a larger sample 
is needed to investigate the familial association property of 
PM and NSS. Moreover, genotypic and longitudinal data 
are needed before it is possible to examine whether the 
putative endophenotypes fulfill Gottesman and Gould’s [6] 
other criteria and their relevance to clinical outcome.  
Few endophenotype research projects examine both 
scientific and clinical research questions with translational  
 
Figure 2  Prospective memory performance among the patients with 
schizophrenia, their first-degree siblings, and healthy subjects. Seti_PM, 
semantic time-based PM; peev_PM, perceptual event-based PM; seev_PM, 
semantic event-based PM; peti_PM, perceptual time-based PM. 
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potential. The COGS (Consortium on the Genetics of Schizo-     
phrenia) and Glahn et al.’s endophenotype project [20] focus 
on examining candidate endophenotypes based on Gottesman’s 
criteria but not clinical outcome. Our research-based clinical 
programme has the advantage of linking neurocognitive 
endophenotypes to clinical outcome measures and to examine 
their relationship. The neurocognitive measures (e.g., social 
cognition and prospective memory) we use in this project 
are believed to be more closely related to everyday function-   
ing than measurements of traditional neurocognitive func-     
tions such as working memory, attention, and executive 
functions. Distinct from similar projects (such as the COGS) 
in Western countries, we are able to carry out endopheno-     
typing at the drug-naive stage for most of our research 
subjects and on patients with bipolar disorder. Other 
benefits of incorporating research study into a clinical 
programme include the ease in subject recruitment, and the 
opportunity to rigorously examine the predictive properties 
of neurocognitive endophenotype on clinical outcomes. 
Moreover, it provides an opportunity for clinicians to detect 
subtle neurocognitive deterioration early in the course of 
illness and to arrange cognitive rehabilitation programmes 
in a timely manner, which is of potential benefit to patients.  
Nevertheless, several limitations of this programme 
should be borne in mind. Firstly, as we recruit all subjects 
and their families who enter the early intervention service 
naturalistically, the samples contain multiple diagnostic 
categories and this heterogeneity may reduce the contrast in 
endophenotypic traits between probands and siblings needed 
to maximise the power of genetic analysis, as compared to 
the COGS. Secondly, there is limited empirical evidence in 
previous studies for shared endophenotypic profiles between 
schizophrenia and bipolar disorder, and it is uncertain whether 
our recruitment of both groups of diagnoses would further 
complicate the phenotype heterogeneity of our sample and 
therefore undermine the power of the endophenotype strategy. 
Thirdly, this project only collect behavioural data of the 
neurocognitive endophenotypes, but neural substrates 
measured by neuroimaging and event-related potentials 
(ERP) are thought to lie even more proximal to genes than 
behavioural functions. Finally, our sample size remains 
small to date. Because of the limit of service throughput of 
the early intervention service, it is expected that we cannot 
recruit a large sample within a short period of time. 
Therefore, multi-centre collaboration (such as CHINE) is 
clearly necessary in the future. As psychiatric research in 
Mainland China is blooming, we expect more sites to join 
CHINE and more future effort to strive for nationwide 
quality assurance of endophenotype data. 
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